D’Alessandro, Giuseppina Quaglio, Deborah Monaco, Lucia Lauro, Clotilde Ghirga, Francesca Ingallina, Cinzia De Martino, Michela Fucile, Sergio Porzia, Alessandra Di Castro, Maria Bellato, Federica Mastrotto, Francesca Mori, Mattia Infante, Paola Turano, Paola Salmaso, Stefano Caliceti, Paolo Di Marcotullio, Lucia Botta, Bruno Ghini, Veronica Limatola, Cristina Additional file 2: of 1H-NMR metabolomics reveals the Glabrescione B exacerbation of glycolytic metabolism beside the cell growth inhibitory effect in glioma Table S1. List of the endo- and exo-metabolites assigned and analysed over time before and after GlaB treatment. Metabolites realised from GL261 cells after 48 h of treatment are reported separately. The Human Metabolome Database (HMDB) compound ID of each metabolite is also reported. Table S2. The HPLC gradient for the brain extracts analysis. All chromatographic runs were performed at a flow-rate of 0.4 ml/min. Solvent A was Water/Acetonitrile 90:10 with the 0.1% v/v of formic acid, and solvent B was Acetonitrile/Methanol 50:50 with the 0.1% v/v of formic acid. (DOCX 117 kb) Glioma;Hh pathway;Isoflavones;1H-NMR spectroscopy;Metabolomics 2019-08-28
    https://springernature.figshare.com/articles/journal_contribution/Additional_file_2_of_1H-NMR_metabolomics_reveals_the_Glabrescione_B_exacerbation_of_glycolytic_metabolism_beside_the_cell_growth_inhibitory_effect_in_glioma/9740342
10.6084/m9.figshare.9740342.v1